PDCD1 and neoplasm: Once the pharmacodynamic studies had confirmed that L-DOS47 increases tumor pHe in the KPC961-1B6 orthotopic model, we investigated the therapeutic efficacy of L-DOS47 as a monotherapy and in combination with anti-PD1.